GIP receptor antagonist (Sanwa Kagaku Kenkyusho)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGIP receptor antagonist (Sanwa Kagaku Kenkyusho)
Drug Alias Nameglucose-dependent insulinotropic polypeptide receptor antagonist (Sanwa Kagaku Kenkyusho)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor antagonists
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanwa Kagaku Kenkyusho Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanwa Kagaku Kenkyusho Co Ltd
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A